Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Kristensen

Showing results (291-300 of 320) with videos related to

Pageof 32
Sort By:
Scientific Reports|June 18, 2020
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer riskJingjing Liu, Wendy J C Prager-van der Smissen, J Margriet Collée, et al.
Breast Cancer Research : BCR|August 19, 2021
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatmentAnna Morra, Maria Escala-Garcia, Jonathan Beesley, et al.
British Journal of Cancer|August 3, 2021
Mendelian randomisation study of smoking exposure in relation to breast cancer riskHanla A Park, Sonja Neumeyer, Kyriaki Michailidou, et al.
Breast Cancer Research : BCR|January 5, 2022
Common variants in breast cancer risk loci predispose to distinct tumor subtypesThomas U Ahearn, Haoyu Zhang, Kyriaki Michailidou, et al.
Plos One|November 13, 2014
MicroRNA related polymorphisms and breast cancer riskSofia Khan, Dario Greco, Kyriaki Michailidou, et al.
British Journal of Cancer|January 26, 2021
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancersNichola Johnson, Sarah Maguire, Anna Morra, et al.
British Journal of Sports Medicine|November 3, 2022
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation studySuzanne C Dixon-Suen, Sarah J Lewis, Richard M Martin, et al.
Journal of the National Cancer Institute|August 23, 2015
Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian RandomizationBen Zhang, Xiao-Ou Shu, Ryan J Delahanty, et al.
Scientific Reports|August 31, 2019
Two truncating variants in FANCC and breast cancer riskThilo Dörk, Paolo Peterlongo, Arto Mannermaa, et al.
Breast Cancer Research : BCR|June 3, 2014
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control studyNichola Johnson, Frank Dudbridge, Nick Orr, et al.
Pageof 32

Showing results (291-300 of 320) with videos related to

Sort By:
Pageof 32
Scientific Reports|June 18, 2020
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer riskJingjing Liu, Wendy J C Prager-van der Smissen, J Margriet Collée, et al.
Breast Cancer Research : BCR|August 19, 2021
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatmentAnna Morra, Maria Escala-Garcia, Jonathan Beesley, et al.
British Journal of Cancer|August 3, 2021
Mendelian randomisation study of smoking exposure in relation to breast cancer riskHanla A Park, Sonja Neumeyer, Kyriaki Michailidou, et al.
Breast Cancer Research : BCR|January 5, 2022
Common variants in breast cancer risk loci predispose to distinct tumor subtypesThomas U Ahearn, Haoyu Zhang, Kyriaki Michailidou, et al.
Plos One|November 13, 2014
MicroRNA related polymorphisms and breast cancer riskSofia Khan, Dario Greco, Kyriaki Michailidou, et al.
British Journal of Cancer|January 26, 2021
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancersNichola Johnson, Sarah Maguire, Anna Morra, et al.
British Journal of Sports Medicine|November 3, 2022
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation studySuzanne C Dixon-Suen, Sarah J Lewis, Richard M Martin, et al.
Journal of the National Cancer Institute|August 23, 2015
Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian RandomizationBen Zhang, Xiao-Ou Shu, Ryan J Delahanty, et al.
Scientific Reports|August 31, 2019
Two truncating variants in FANCC and breast cancer riskThilo Dörk, Paolo Peterlongo, Arto Mannermaa, et al.
Breast Cancer Research : BCR|June 3, 2014
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control studyNichola Johnson, Frank Dudbridge, Nick Orr, et al.
Pageof 32